● Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Condition: Ulcerative Colitis (UC) · Sponsor: Xencor, Inc.

PhasePhase 1/Phase 2

Planned participants270

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersYes

About this study

The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).

This description comes directly from the study's public registry record.

Talk to the study team

942 Study Information · Xenith-UCinfo@xencor.com

Always discuss trial participation with your own doctor first.

Locations (90)

Xencor Investigative Site	Scottsdale, Arizona, United States	Recruiting
Xencor Investigative Site	Bradenton, Florida, United States	Recruiting
Xencor Investigative Site	Brandon, Florida, United States	Recruiting
Xencor Investigative Site	Jacksonville, Florida, United States	Recruiting
Xencor Investigative Site	Kissimmee, Florida, United States	Recruiting
Xencor Investigative Site	Margate, Florida, United States	Recruiting
Xencor Investigative Site	Palmetto Bay, Florida, United States	Recruiting
Xencor Investigative Site	Tampa, Florida, United States	Recruiting
Xencor Investigative Site	Tampa, Florida, United States	Recruiting
Xencor Investigative Site	Louisville, Kentucky, United States	Recruiting
Xencor Investigative Site	Oxford, Mississippi, United States	Recruiting
Xencor Investigative Site	Tupelo, Mississippi, United States	Recruiting

+ 78 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06619990